Goldman Sachs-owned, DII favorite small-cap inventory drops 6% to hit file low after promoter pledges shares; do you personal?

A small-cap inventory, backed by international monetary big Goldman Sachs and held by fashionable home institutional buyers (DIIs), plunged to a file low in intraday commerce on Thursday, February 13, a day after the corporate disclosed that certainly one of its promoters had pledged shares.

Archean Chemical Industries’ share value crashed as a lot as 6.13 per cent to hit its all-time low of ₹436 Thursday morning after the corporate mentioned one of many promoters pledged shares with Bajaj Finance.

“The corporate has acquired communication at present from one of many promoters, M/s Chemikas Speciality LLP, concerning the pledge of 11,15,000 fairness shares of ₹2 every of the corporate held by them (2.96 per cent of complete holdings of Chemikas Speciality LLP and 0.90 per cent of complete fairness capital of the corporate) with Bajaj Finance Restricted on twelfth February 2025,” Archean Chemical mentioned in an alternate submitting post-market hours on Wednesday, February 12.

The small-cap inventory opened at ₹450.55 on Thursday in opposition to its earlier shut of ₹464.45 and traded unstable after hitting a file low. Round 11:10 AM, Archean Chemical Industries share value was 2 per cent down at ₹455.25.

Goldman Sachs, DIIs maintain stakes in Archean Chemical Industries

In accordance with the December quarter (Q3FY25) shareholding sample information, overseas portfolio buyers (FPIs) held 1,31,38,918 shares, aggregating to 10.65 per cent stake, within the firm by the tip of the final quarter (Q3FY25).

By the tip of the December quarter, Goldman Sachs Funds by way of Goldman Sachs India Fairness Portfolio held 30,38,345 shares or a 2.46 per cent stake within the firm.

Home Institutional Traders (DIIs), which comprise mutual funds, insurance coverage firms, banks and NBFCs, pension and provident funds, alternate funding funds (AIFs) and improvement monetary establishments, collectively held 2,82,08,506 shares, or 22.85 per cent stake, of the corporate.

From the mutual funds’ area, Nippon Life India Trustee Ltd (Nippon India Small Cap Fund) held 1.17 per cent, Hdfc Mutual Fund (HDFC Multi Cap Fund) held 1.53 per cent, DSP Small Cap Fund held 3.44 per cent and SBI Small Cap Fund held 6.92 per cent stakes within the firm within the December quarter of FY25.

Among the many insurance coverage firms, ICICI Lombard Common Insurance coverage Firm held a 1.06 per cent stake, whereas Tata AIA Life Insurance coverage Firm held a 2.25 per cent stake in the course of the quarter.

Nonetheless, it can’t be ascertained at this juncture whether or not these FPIs and DIIs nonetheless maintain the identical stake within the firm talked about above. If relevant, the shareholding sample information for the March quarter will reveal any adjustments of their holdings.

Archean Chemical Industries share value pattern

The small-cap inventory hit a 52-week excessive of ₹838.20 on February 27 final 12 months. Nonetheless, it has been underneath promoting strain since then.

During the last 12 months, the inventory has declined 33 per cent to hit its all-time low. On a month-to-month scale, the inventory has been since December.

Archean Chemical Industries Q3 outcome

The corporate reported a revenue after tax (PAT) of ₹56.29 crore in Q3FY25, down 44.92 per cent in opposition to a revenue of ₹102.19 core within the corresponding quarter of the earlier monetary 12 months.

EBITDA dropped 38.24 per cent year-on-year to ₹96.33 crore from ₹155.98 crore in the identical quarter final 12 months.

Complete revenue in the course of the quarter fell 39.8 per cent year-on-year to ₹254.66 crore from ₹422.72 crore in Q3FY24.

Learn all market-related information right here

Learn extra tales by Nishant Kumar

Disclaimer: The views and suggestions above are these of particular person analysts, consultants, and brokerage corporations, not Mint. We advise buyers to seek the advice of licensed consultants earlier than making any funding selections.